{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:51:10Z","timestamp":1780321870598,"version":"3.54.1"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.coi.2025.102618","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T19:36:50Z","timestamp":1753731410000},"page":"102618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Can we cure vasculitis?"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4093-0515","authenticated-orcid":false,"given":"Meghan E","family":"Free","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic J","family":"Ciavatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2025.102618_bib1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ekir.2019.01.004","article-title":"Understanding long-term remission off therapy in antineutrophil cytoplasmic autoantibody-associated vasculitis","volume":"4","author":"Hogan","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.coi.2025.102618_bib2","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.2215\/CJN.02500317","article-title":"ANCA glomerulonephritis and vasculitis","volume":"12","author":"Jennette","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.coi.2025.102618_bib3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nrrheum.2014.89","article-title":"Vasculitis: determinants of disease patterns","volume":"10","author":"Hoffman","year":"2014","journal-title":"Nat Rev Rheuma"},{"key":"10.1016\/j.coi.2025.102618_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000442323","article-title":"Overview of the pathogenesis of ANCA-associated vasculitis","volume":"1","author":"Xiao","year":"2016","journal-title":"Kidney Dis"},{"key":"10.1016\/j.coi.2025.102618_sbref5","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1681\/ASN.2021081142","article-title":"Immunological interaction of HLA-DPB1 and proteinase 3 in ANCA vasculitis is associated with clinical disease activity","volume":"33","author":"Chen","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.coi.2025.102618_bib6","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.kint.2020.04.037","article-title":"ANCA autoantigen gene expression highlights neutrophil heterogeneity where expression in normal-density neutrophils correlates with ANCA-induced activation","volume":"98","author":"Jones","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.coi.2025.102618_sbref7","doi-asserted-by":"crossref","first-page":"e166107","DOI":"10.1172\/jci.insight.166107","article-title":"PRTN3 variant correlates with increased autoantigen levels and relapse risk in PR3-ANCA versus MPO-ANCA disease","volume":"8","author":"Chen","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.coi.2025.102618_bib8","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1681\/ASN.2016050548","article-title":"Gene-specific DNA methylation changes predict remission in patients with ANCA-associated vasculitis","volume":"28","author":"Jones","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.coi.2025.102618_bib9","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2025.102618_sbref10","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1038\/s41588-024-01937-x","article-title":"Enhancing the Polygenic Score Catalog with tools for score calculation and ancestry normalization","volume":"56","author":"Lambert","year":"2024","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2025.102618_bib11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41588-021-00783-5","article-title":"The Polygenic Score Catalog as an open database for reproducibility and systematic evaluation","volume":"53","author":"Lambert","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2025.102618_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2023-000554","article-title":"Performance of polygenic risk scores in screening, prediction, and risk stratification: secondary analysis of data in the Polygenic Score Catalog","volume":"2","author":"Hingorani","year":"2023","journal-title":"BMJ Med"},{"key":"10.1016\/j.coi.2025.102618_bib13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically distinct subsets within ANCA-associated vasculitis","volume":"367","author":"Lyons","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2025.102618_bib14","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/art.40034","article-title":"Identification of functional and expression polymorphisms associated with risk for antineutrophil cytoplasmic autoantibody-associated vasculitis","volume":"69","author":"Merkel","year":"2017","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.coi.2025.102618_bib15","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nrg1489","article-title":"Gene map of the extended human MHC","volume":"5","author":"Horton","year":"2004","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.coi.2025.102618_bib16","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1002\/art.38036","article-title":"Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis","volume":"65","author":"Xie","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coi.2025.102618_bib17","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1681\/ASN.2010101058","article-title":"DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans","volume":"22","author":"Cao","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.coi.2025.102618_bib18","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1002\/art.27742","article-title":"Alpha\u2081-antitrypsin deficiency-related alleles Z and S and the risk of Wegener's granulomatosis","volume":"62","author":"Mahr","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coi.2025.102618_bib19","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1002\/art.21487","article-title":"The PTPN22 620W allele is a risk factor for Wegener's granulomatosis","volume":"52","author":"Jagiello","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coi.2025.102618_bib20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ncprheum0895","article-title":"Nature and functions of autoantibodies","volume":"4","author":"Elkon","year":"2008","journal-title":"Nat Clin Pr Rheuma"},{"key":"10.1016\/j.coi.2025.102618_bib21","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2215\/CJN.10411012","article-title":"Relation between asymptomatic proteinase 3 antibodies and future granulomatosis with polyangiitis","volume":"8","author":"Olson","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.coi.2025.102618_bib22","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1172\/JCI65292","article-title":"Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis","volume":"123","author":"Roth","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2025.102618_bib23","doi-asserted-by":"crossref","first-page":"A293","DOI":"10.1016\/j.autrev.2009.10.008","article-title":"The environment, geoepidemiology and ANCA-associated vasculitides","volume":"9","author":"Chen","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.coi.2025.102618_bib24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.imbio.2011.12.009","article-title":"Environmental factors producing autoimmune dysregulation--chronic activation of T cells caused by silica exposure","volume":"217","author":"Lee","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.coi.2025.102618_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102660","article-title":"Environmental risk factors associated with ANCA associated vasculitis: a\u00a0systematic mapping review","volume":"19","author":"Scott","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.coi.2025.102618_bib26","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2215\/CJN.03501006","article-title":"Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study","volume":"2","author":"Hogan","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.coi.2025.102618_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02828275","article-title":"ANCA-associated diseases and silica exposure","volume":"15","author":"Gregorini","year":"1997","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.coi.2025.102618_bib28","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1080\/15428110208984765","article-title":"Exposure to respirable crystalline silica in eastern North Carolina farm workers","volume":"63","author":"Archer","year":"2002","journal-title":"Aiha J (Fairfax Va )"},{"key":"10.1016\/j.coi.2025.102618_bib29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1047-2797(03)00007-3","article-title":"Assessing exposure to crystalline silica from farm work: a population-based study in the Southeastern United States","volume":"13","author":"Parks","year":"2003","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.coi.2025.102618_bib30","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/BOR.0b013e328346c332","article-title":"Bacterial infections in Wegener's granulomatosis: mechanisms potentially involved in autoimmune pathogenesis","volume":"23","author":"Tadema","year":"2011","journal-title":"Curr Opin Rheuma"},{"key":"10.1016\/j.coi.2025.102618_bib31","article-title":"Plasma from patients with anti-glomerular basement membrane disease could recognize microbial peptides","volume":"12","author":"Li","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2025.102618_bib32","first-page":"130","article-title":"Cutaneous and systemic manifestations of drug-induced vasculitis","volume":"36","author":"ten Holder","year":"2002","journal-title":"Ann Pharm"},{"key":"10.1016\/j.coi.2025.102618_bib33","article-title":"Drug-induced vasculitis: a review of cutaneous and systemic manifestations","volume":"120","author":"ten Holder","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coi.2025.102618_sbref34","doi-asserted-by":"crossref","first-page":"e178813","DOI":"10.1172\/JCI178813","article-title":"Sequential carbonyl derivatives and hydrazone adduct formation on myeloperoxidase contribute to development of ANCA-vasculitis","volume":"135","author":"Xi","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2025.102618_bib35","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1172\/JCI113710","article-title":"Analysis of renal fibrosis in a rabbit model of crescentic nephritis","volume":"82","author":"Downer","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2025.102618_bib36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-0038-1673386","article-title":"Pathogenesis of ANCA-associated pulmonary vasculitis","volume":"39","author":"Alba","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.coi.2025.102618_bib37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res"},{"key":"10.1016\/j.coi.2025.102618_bib38","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.semnephrol.2013.08.006","article-title":"Complement in ANCA-associated vasculitis","volume":"33","author":"Charles Jennette","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.coi.2025.102618_bib39","doi-asserted-by":"crossref","first-page":"J276","DOI":"10.1016\/j.jaut.2009.11.014","article-title":"The complement system in systemic autoimmune disease","volume":"34","author":"Chen","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.coi.2025.102618_bib40","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.coi.2025.102618_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"13","author":"Duan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102618_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1122586","article-title":"The role of NOD-like receptors in innate immunity","volume":"14","author":"Almeida-da-Silva","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102618_bib43","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/cdd.2011.1","article-title":"Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality","volume":"18","author":"Remijsen","year":"2011","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.coi.2025.102618_bib44","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2025.102618_bib45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/1744666X.2024.2405170","article-title":"Complement as a major mediator of ANCA vasculitis and a target for precision therapy","volume":"21","author":"Bunch","year":"2025","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.coi.2025.102618_bib46","series-title":"Immunology for Pharmacy","first-page":"23","article-title":"Chapter 3 - Immunogenicity and antigenicity","author":"Flaherty","year":"2012"},{"key":"10.1016\/j.coi.2025.102618_bib47","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1097\/01.ASN.0000135058.46193.72","article-title":"Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis","volume":"15","author":"Yang","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.coi.2025.102618_bib48","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/art.27398","article-title":"Transcription of proteinase 3 and related myelopoiesis genes in peripheral blood mononuclear cells of patients with active Wegener's granulomatosis","volume":"62","author":"Cheadle","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coi.2025.102618_bib49","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1172\/JCI40034","article-title":"Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis","volume":"120","author":"Ciavatta","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2025.102618_bib50","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1002\/art.39153","article-title":"Neutrophil-related gene expression and low-density granulocytes associated with disease activity and response to treatment in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"67","author":"Grayson","year":"2015","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.coi.2025.102618_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02603","article-title":"Low density granulocytes in ANCA vasculitis are heterogenous and hypo-responsive to anti-myeloperoxidase antibodies","volume":"10","author":"Ui Mhaonaigh","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102618_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2025.105412","article-title":"Aberrant oxidative modifications of neutrophil myeloperoxidase in anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"315","author":"Sato","year":"2025","journal-title":"J Proteom"},{"key":"10.1016\/j.coi.2025.102618_bib53","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1002\/art.37959","article-title":"Patients with antineutrophil cytoplasmic antibody-associated vasculitis have defective treg cell function exacerbated by the presence of a suppression-resistant effector cell population","volume":"65","author":"Free","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coi.2025.102618_bib54","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00281-014-0436-6","article-title":"The immunopathology of ANCA-associated vasculitis","volume":"36","author":"McKinney","year":"2014","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.coi.2025.102618_bib55","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2337\/dbi18-0058","article-title":"Function, failure, and the future potential of tregs in type 1 diabetes","volume":"70","author":"Bettini","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.coi.2025.102618_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.635767","article-title":"Emerging therapeutic strategies to restore regulatory T cell control of islet autoimmunity in type 1 diabetes","volume":"12","author":"Volfson-Sedletsky","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102618_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021752","article-title":"Treg therapy for the induction of immune tolerance in transplantation\u2014not lost in translation?","volume":"24","author":"Pilat","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coi.2025.102618_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-024-01952-8","article-title":"Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders","volume":"9","author":"Song","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.coi.2025.102618_bib59","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/83707","article-title":"X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy","volume":"27","author":"Wildin","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2025.102618_bib60","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2025.102618_bib61","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/83784","article-title":"Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse","volume":"27","author":"Brunkow","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2025.102618_sbref62","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1428","article-title":"The frequency of Treg subsets distinguishes disease activity in ANCA vasculitis","volume":"11","author":"Agosto-Burgos","year":"2022","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.coi.2025.102618_bib63","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jaut.2019.05.005","article-title":"IL233, an IL-2-IL-33 hybrid cytokine induces prolonged remission of mouse lupus nephritis by targeting Treg cells as a single therapeutic agent","volume":"102","author":"Stremska","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.coi.2025.102618_bib64","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jaut.2017.12.010","article-title":"Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells","volume":"89","author":"Prasad","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.coi.2025.102618_bib65","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1126\/science.adg7505","article-title":"Restoring tolerance with antigen delivery","volume":"383","author":"Jabri","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.coi.2025.102618_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/nu16193237","article-title":"Peanut allergy in children-is prevention better than cure?","volume":"16","author":"Krejner-Bienias","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.coi.2025.102618_bib67","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(21)02390-4","article-title":"Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study","volume":"399","author":"Jones","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2025.102618_bib68","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1681\/ASN.2015010089","article-title":"Myeloperoxidase peptide-based nasal tolerance in experimental ANCA-associated GN","volume":"27","author":"Gan","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.coi.2025.102618_bib69","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.aaf6756","article-title":"Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease","volume":"353","author":"Ellebrecht","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.coi.2025.102618_sbref70","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1335998","article-title":"Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases","volume":"15","author":"Perico","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102618_bib71","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1172\/JCI69187","article-title":"Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis","volume":"123","author":"Macauley","year":"2013","journal-title":"J Clin Invest"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525000949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525000949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T13:22:38Z","timestamp":1757337758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791525000949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":71,"alternative-id":["S0952791525000949"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2025.102618","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can we cure vasculitis?","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2025.102618","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102618"}}